SAMD9 antibody (Cy3)

Catalog No. ABIN1418135

Product Details anti-SAMD9 Antibody (Cy3)

Target: SAMD9 (Sterile alpha Motif Domain Containing 9 (SAMD9))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SAMD9 antibody is conjugated to Cy3

Application: Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Cross-Reactivity: Human, Mouse, Rat

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human SAMD9

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for SAMD9

Target: SAMD9 (Sterile alpha Motif Domain Containing 9 (SAMD9))

Alternative Name: SAMD9 (SAMD9 Products)

Synonyms: C7orf5 antibody, DRIF1 antibody, NFTC antibody, OEF1 antibody, OEF2 antibody, sterile alpha motif domain containing 9 antibody, SAMD9 antibody

Background:

Synonyms: SAM domain-containing protein 9, SAMD9, SAMD9_HUMAN, sterile alpha mot domain containing 9, Sterile alpha mot domain-containing protein 9, C7orf5.

Background: Defects in SAMD9 are the cause of normophosphatemic familial tumoral calcinosis (NFTC). NFTC is an uncommon life-threatening disorder characterized by massive periarticular, and seldom visceral, deposition of calcified tumors.

Gene ID: 54809